Skip to main content
. 2017 Jul 15;8(7):381–389. doi: 10.4239/wjd.v8.i7.381

Table 13.

Change in HbA1c % before and after autologous bone marrow derived stem cell therapy in Group I

Patient Baseline 3 mo 6 mo 12 mo 18 mo 24 mo
1 7.2 5.7 7.1 6.4 6.8 7.3
2 6.7 6.2 6.7 6.9 6 -
3 6 - 6.4 5.7 - -
4 7 6.8 6.6 - - -
5 6.1 6.3 5.9 - - -
6 6.9 6.5 6.4 - - -
7 Lost to FU
Mean ± SE 6.8 ± 0.18 6.3 ± 0.18 6.5 ± 0.16
P value 0.164 0.355